LAGRECA, IVANA
 Distribuzione geografica
Continente #
NA - Nord America 3.353
EU - Europa 1.464
AS - Asia 1.389
SA - Sud America 170
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 44
OC - Oceania 4
Totale 6.501
Nazione #
US - Stati Uniti d'America 3.249
IT - Italia 423
SG - Singapore 395
CN - Cina 332
GB - Regno Unito 311
HK - Hong Kong 168
VN - Vietnam 167
SE - Svezia 148
DE - Germania 126
BR - Brasile 116
FI - Finlandia 109
BD - Bangladesh 102
RU - Federazione Russa 89
FR - Francia 72
TR - Turchia 49
CA - Canada 41
UA - Ucraina 38
IN - India 36
KR - Corea 28
MX - Messico 22
ID - Indonesia 20
NL - Olanda 19
AR - Argentina 18
BG - Bulgaria 18
ES - Italia 16
BE - Belgio 15
IL - Israele 13
CR - Costa Rica 12
PL - Polonia 12
IE - Irlanda 11
IQ - Iraq 11
LT - Lituania 11
ZA - Sudafrica 11
AT - Austria 10
EC - Ecuador 10
JP - Giappone 9
CO - Colombia 8
CZ - Repubblica Ceca 8
CL - Cile 7
MA - Marocco 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
SC - Seychelles 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
EG - Egitto 5
JM - Giamaica 5
KE - Kenya 5
PK - Pakistan 5
AU - Australia 4
EU - Europa 4
GR - Grecia 4
MY - Malesia 4
NI - Nicaragua 4
TW - Taiwan 4
VE - Venezuela 4
BZ - Belize 3
CY - Cipro 3
DK - Danimarca 3
DZ - Algeria 3
GP - Guadalupe 3
IR - Iran 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
SV - El Salvador 3
TN - Tunisia 3
AL - Albania 2
BN - Brunei Darussalam 2
CW - ???statistics.table.value.countryCode.CW??? 2
HN - Honduras 2
KH - Cambogia 2
LB - Libano 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
A1 - Anonimo 1
BO - Bolivia 1
CH - Svizzera 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
NP - Nepal 1
QA - Qatar 1
Totale 6.427
Città #
Ashburn 460
Fairfield 312
Santa Clara 256
Singapore 247
Southend 193
Woodbridge 192
Hong Kong 166
Chandler 161
San Jose 146
Seattle 124
Ann Arbor 115
Houston 113
Wilmington 100
Nyköping 86
Council Bluffs 85
Cambridge 84
Dearborn 84
Helsinki 83
Hefei 69
New York 64
Modena 62
Beijing 61
London 55
Ho Chi Minh City 54
Munich 47
Jacksonville 46
Los Angeles 40
Hanoi 34
Milan 33
Chicago 29
Boardman 28
Seoul 27
The Dalles 27
Fremont 25
Bologna 21
Izmir 21
Dallas 20
Moscow 20
Columbus 18
San Diego 17
Sofia 17
Buffalo 16
Bremen 15
Lauterbourg 15
Princeton 15
Brussels 14
Eugene 14
Jakarta 14
Shanghai 14
Montreal 13
Reggio Emilia 13
Turku 13
Brooklyn 12
Rome 11
São Paulo 11
Toronto 11
Redwood City 10
Chennai 9
Da Nang 9
Dublin 9
Orem 9
Parma 9
Stockholm 9
Washington 9
Atlanta 8
Frankfurt am Main 8
Paris 8
Haiphong 7
Jinan 7
Naples 7
North Bergen 7
San José 7
Johannesburg 6
Pavia 6
Tokyo 6
Vienna 6
Warsaw 6
Baghdad 5
Kingston 5
Mexico City 5
Mumbai 5
Nairobi 5
New Orleans 5
Phoenix 5
Redondo Beach 5
Tashkent 5
Wuhan 5
Boydton 4
Brescia 4
Carpi 4
Catania 4
Changsha 4
Delhi 4
Denver 4
Detroit 4
Deventer 4
Dhaka 4
Dong Ket 4
Grave 4
Hillsboro 4
Totale 4.307
Nome #
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 451
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 425
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 400
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 399
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 387
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 377
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 368
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 363
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 358
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 343
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 328
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 302
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 301
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 286
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 280
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 239
Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (NPM1) gene mutation subtypes: a single-center experience and review of the literature 215
Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience 210
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 172
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 168
The dynamic functions of IRF4 in B cell malignancies 129
Totale 6.501
Categoria #
all - tutte 24.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022254 0 0 0 0 2 13 16 41 36 36 76 34
2022/2023486 64 65 25 47 71 44 17 49 41 6 24 33
2023/2024404 10 19 40 36 54 49 45 82 4 7 28 30
2024/20251.012 38 26 31 73 172 129 106 65 90 44 97 141
2025/20261.951 174 69 122 182 253 130 254 103 221 175 105 163
2026/2027499 53 103 110 186 47 0 0 0 0 0 0 0
Totale 6.501